CELLECTIS - ADR (CLLS:NASDAQ)
$2.99 -0.183 (-5.7674%)
Analysed CELLECTIS - ADR (CLLS:NASDAQ) News Sources
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Tuesday Trading
16-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Little Changed in Thursday Trading
18-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
22-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
24-06-2026
yahoo.com
European Equities Traded in US as ADRs Rise in Thursday Trading
25-06-2026
yahoo.com
Cellectis Reports Results from Shareholders Meeting Held on June 25, 2026
25-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading
29-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
30-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading
02-07-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Decline Sharply in Wednesday Trading
08-07-2026
yahoo.com
What is the current price of CELLECTIS - ADR (CLLS:NASDAQ)?
The current price of CELLECTIS - ADR (CLLS:NASDAQ) is $2.99.
CELLECTIS - ADR (CLLS:NASDAQ) absolute price change since previous trading day?
The absolute price change of CELLECTIS - ADR (CLLS:NASDAQ) since the previous trading day is $-0.183.
CELLECTIS - ADR (CLLS:NASDAQ) percentage price change since previous trading day?
The percentage price change of CELLECTIS - ADR (CLLS:NASDAQ) since the previous trading day is -5.7674%.
What is the most recent average sentiment score for CELLECTIS - ADR (CLLS:NASDAQ)?
The most recent average sentiment score for CELLECTIS - ADR (CLLS:NASDAQ) is 24 out of 100.
What is the most recent average sentiment for CELLECTIS - ADR (CLLS:NASDAQ)?
The most recent sentiment for CELLECTIS - ADR (CLLS:NASDAQ) is .
SEC-8K** Filing Available For CELLECTIS - ADR (CLLS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.